Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Jingquan Ji"'
Autor:
Xiao Duan, Qiang Wang, Yue Wang, Xinping Liu, Manman Lu, Zhifang Li, Xuelian Jiang, Jingquan Ji
Publikováno v:
Pharmaceutics, Vol 16, Iss 9, p 1178 (2024)
Using an endogenous carrier is the best method to address the biocompatibility of carriers in the drug delivery field. Herein, we prepared a glutathione-responsive paclitaxel prodrug micelle based on an endogenous molecule of L-glutathione oxidized (
Externí odkaz:
https://doaj.org/article/6bb4736e7f7c4c6492fba6e88d5efa04
Publikováno v:
Bioengineered, Vol 12, Iss 1, Pp 8057-8066 (2021)
Bioengineered
article-version (VoR) Version of Record
Bioengineered
article-version (VoR) Version of Record
Liraglutide, a glucagon-like peptide 1 (GLP1) receptor agonist, is known to inhibit the atherosclerosis of apoE mice and suppress the cellular behaviors of VSMCs induced by AngII. This study aimed to explore whether liraglutide can reduce the prolife
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2937fbccf911596cdc55ec38ff1552b9
https://doaj.org/article/d32557e907c9474787f0a52f36474b65
https://doaj.org/article/d32557e907c9474787f0a52f36474b65
Publikováno v:
Wireless and Satellite Systems ISBN: 9783030933975
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ce22035fb137be1011ec26fd2d854921
https://doi.org/10.1007/978-3-030-93398-2_13
https://doi.org/10.1007/978-3-030-93398-2_13
Publikováno v:
Experimental and Therapeutic Medicine
Long non-coding (lnc)RNA HAND2 antisense RNA 1 (HAND2-AS1) exhibited tumor suppression activity in different types of cancer. However, its role in cervical squamous cell carcinoma (CSCC), which is frequently diagnosed among females, has not been eluc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb4624814dbd793b083dbee455780521
http://europepmc.org/articles/PMC6755406
http://europepmc.org/articles/PMC6755406
Autor:
Elle C. Moore, Gerard C. Blobe, Nicholas C. DeVito, Brent A. Hanks, Michael R. Harrison, Christopher J. Hoimes, Jingquan Jia, Michael A. Morse, Parvathy Jayaprakasan, Andrew MacKelfresh, Hillary Mulder, Adam J. Hockenberry, Alia Zander, Martin C. Stumpe, Jackson Michuda, Kyle A. Beauchamp, Eric Perakslis, Timothy Taxter, Daniel J. George
Publikováno v:
Cancer Medicine, Vol 12, Iss 19, Pp 19394-19405 (2023)
Abstract Background Roughly 5% of metastatic cancers present with uncertain origin, for which molecular classification could influence subsequent management; however, prior studies of molecular diagnostic classifiers have reported mixed results with
Externí odkaz:
https://doaj.org/article/b59390dd42bb4274953a6323c81735b6
Autor:
Hui Pang, Limin Wang, Dewu Han, Jianhong Guo, Xujiong Li, Xiaoxia Tian, Jingquan Ji, Yanjun Wu, Yimin Fan, Zhongfu Zhao, Lili Zhang, Minli Lv, Baohong Li, Yan Liu, Lina Lai, Cheng Ji, Chen Li, Cuiying Zhang, Jiantao Jia, Huiying Zhang
Publikováno v:
Gene. 537:115-119
Objective This study is to explore the role of 78 kD glucose-regulated protein (GRP78) in the development of hepatopulmonary syndrome (HPS) in rats. Methods The rat model of liver cirrhosis and HPS were induced with multiple pathogenic factors. Hemat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08201741d4584507614f20212aea6765
https://doi.org/10.1016/j.gene.2013.11.065
https://doi.org/10.1016/j.gene.2013.11.065
Autor:
Peng Xiao, Xiaoxia Tian, Jiantao Jia, Jianhong Guo, Dewu Han, Lili Zhang, Mingshe Liu, Chen Li, Minli Lv, Jingquan Ji, Cuiying Zhang, Baohong Li, Cheng Ji, Yan Liu, Limin Wang, Huiying Zhang, Yimin Fan, Xujiong Li, Zhongfu Zhao, Lina Lai
Objective This study is to investigate the role of glucose-regulated protein 78 (GRP78) in the pulmonary microvascular remodeling during hepatopulmonary syndrome (HPS) development. Methods The rat models with liver cirrhosis and HPS were induced by m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::987a050b432482825c0afa036772d2bb
https://europepmc.org/articles/PMC4497504/
https://europepmc.org/articles/PMC4497504/
Publikováno v:
Frontiers in Oncology, Vol 8 (2018)
MET amplification is rare in treatment-naïve metastatic colorectal cancer (CRC) tumors, but can emerge as a mechanism of resistance to anti-EGFR therapies. Preclinical and clinical data suggest that patients with MET amplified tumors benefit from ME
Externí odkaz:
https://doaj.org/article/c8148f9916b94804b50aaa1ccf125047